MedTech pioneer Max Reinhardt joins eXeX to drive Canopus platform growth

The Johnson & Johnson, Pacira BioSciences and Orthofix executive takes charge of commercial executionplaceholder image
The Johnson & Johnson, Pacira BioSciences and Orthofix executive takes charge of commercial execution | eXeX

MedTech leader Max Reinhardt is set to drive the growth of eXeX's Canopus platform, accelerating the adoption of surgery intelligence in the UK.

eXeX, a global surgery intelligence company, announced the appointment of Max Reinhardt as president of healthcare. Reinhardt, who has held senior leadership roles in MedTech and pharmaceuticals, will drive the company's commercial execution, bringing surgery intelligence into hospital systems across the United States, the United Kingdom, and beyond.

Canopus by eXeX is the world's first surgery intelligence platform, designed to transform the experience in the operating room (OR) by presenting surgeon, surgery, and OR-specific setup and step-by-step procedure execution plans in real time. Canopus utilises touch-free technology, digitising the experience and knowledge of the most capable teams for every OR, every surgeon, and every surgery.

The solution reduces surgeon cognitive load, facilitates effective OR teamwork, enables improved OR productivity, and is non-clinical by design, requiring no EHR integration and excluding any patient data for ease of adoption. Canopus optimises preparation, orchestrates the OR in real time, and turns every case into a planned, structured, informed operation, with the ability for the team to continually optimise the plan as required at any time.

The appointment caps a period of accelerated quarter-over-quarter growth. Canopus is deployed across multiple hospital groups in the United States and United Kingdom and has supported several thousand live surgeries, proven first where surgery is most complex (spine and orthopaedics) and built for all of surgery.

"The operating room is the most complex workspace on Earth. It deserves intelligent infrastructure, and it deserves leaders who have lived inside it," said Robert Masson, MD, chairman and CEO of eXeX and a practicing neurological spine surgeon. "Max has spent three decades putting the world's most advanced surgical technology into the hands of teams on every continent. There is no better person to lead our commercial efforts at this exciting time."

eXeX also announced Canopus Commandplaceholder image
eXeX also announced Canopus Command | eXeX

Reinhardt brings more than three decades of global MedTech and pharmaceutical executive leadership experience, including seventeen years with Johnson & Johnson. He started with J&J at DePuy Spine in the United Kingdom in 2002 and rose to vice president of worldwide marketing for DePuy Synthes, accountable for $5.5 billion in orthopaedics revenue with responsibility for joint reconstruction, trauma, craniomaxillofacial, spine, and sports medicine. His president-level roles span the industry's most competitive categories:

  1. President, Global Spine, Orthofix Medical (NASDAQ: OFIX), 2024: leading the company's global spine and biologics business
  2. President, Pacira BioSciences 2019: overseeing all commercial and medical affairs
  3. Worldwide President, DePuy Synthes Spine (the spine division of Johnson & Johnson) 2013: driving the business to the number-two market-share position in the global spine market
  4. Worldwide President, Joint Reconstruction, Sports Medicine & Power Tools, DePuy Synthes, a Johnson & Johnson company

Earlier in his career, Reinhardt held senior leadership positions with Steris and Olympus in Europe.

"I have spent thirty years bringing innovation to surgeons and operating rooms globally. eXeX is transforming one of the most complex and demanding work environments - the OR, where planning, communication, teamwork and execution are vital to a great outcome," said Reinhardt. "The best surgical teams in the world run on memory and tribal knowledge. For the first time, that experience and know-how can be captured and delivered, making every case the team's best case. This is a once-in-a-generation shift that is long overdue, and eXeX is leading it."

Reinhardt joins recently appointed chief 0perating 0fficer John Spranger to form the leadership team driving surgery intelligence. Alongside Dr. Masson, their mandate is to bring Canopus by eXeX to every OR, for every surgeon and every surgery.

eXeX also announced Canopus Command, an intelligent portal that gives hospital staff and leadership a live operational view inside every case. Every procedure generates operational data (setup accuracy, workflow timing, supply utilisation, onboarding velocity) that until now disappeared the moment the case ended. With Canopus Command, hospitals see it in real time.

At its heart is a breakthrough measurement: the surgical inquiry, the discrete moment a team member pulls the exact information they need for the case in front of them. Tracked across a facility, surgical inquiries reveal where demand is concentrating (by procedure, by team, and by moment in the workflow) so leadership can move resources and personnel ahead of the need, not after it.

Related topics:
Celebrating 135 years of telling Leeds' stories
Follow us
© 2026 Iconic Media Group Ltd. All rights reserved.Cookie SettingsTerms and ConditionsPrivacy notice